Advertisement

Mom's Blood Reveals Baby's Down Syndrome

Last week researchers released the first non-invasive prenatal test for Down syndrome, and more such tests are expected in the coming months.

By | October 25, 2011

image: Mom's Blood Reveals Baby's Down Syndrome Wikimedia Commons, Canwest News Service

WIKIMEDIA COMMONS, CANWEST NEWS SERVICE

Finally there is an alternative to poking a needle into a mother's womb to test her baby for genetic abnormalities. Last week (October 17), researchers at Sequenom, a genetic diagnostics manufacturer based in San Diego, California, announced the release of MaterniT21, which uses a sample of the mother's blood to test for Down syndrome in the fetus. Specifically, it measures the abundance of DNA that comes from chromosome 21—normally around 1.35 percent of the DNA in the blood. An overabundance of chromosome 21 sequences suggests the fetus may have Down's, which results from carrying an extra copy of the chromosome.

The test boasts a false positive rate of just 0.2 percent, and is being marketed as an additional test to follow up on ultrasound predictions of Down's, which carry a 5 percent false positive rate.

According to Nature, MaterniT21 is the first of many, as prenatal genetic screening enters "a long-anticipated era" of non-invasive testing. "There's every reason to think that in the future you'll be able to extract an enormous amount of information from [the fetal DNA carried in the mother's blood]," Peter Benn, director of the Diagnostic Human Genetics Laboratories at the University of Connecticut Health Center in Farmington, told Nature.

While such tests could decrease the number of women who have amniocentesis—a procedure involving the extraction of a small amount of fluid from the amniotic sac, which risks injuring the baby's limbs and even miscarriage—bioethicists worry that the availability of non-invasive procedures could raise other issues, such as the decision of whether or not to keep an unhealthy fetus or the possibility that parents will make such choices on less serious conditions.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Carlos Trujillo

Carlos Trujillo

Posts: 1457

October 26, 2011

Why they didn't announced at the International Congress of Human Genetics in Montreal from the 11 to 15th of October. Sequenom had a boot at that Conference, I ask them and they reply that will be released early next year...
Carlos

Avatar of: Tyler Best

Tyler Best

Posts: 1

October 26, 2011

A common editing mistake is to call trisomy 21 "Down's syndrome" when it is properly written "Down syndrome"---no possessive apostrophe S---

Avatar of: TheSciAdmin

TheSciAdmin

Posts: 56

October 26, 2011

Hi Tyler,

Thanks for your comment. You are right that the accepted American spelling is Down syndrome. I have corrected this post to reflect that spelling.

Thanks for reading!
~Jef Akst, editor, The Scientist

Avatar of:

Posts: 0

October 26, 2011

Why they didn't announced at the International Congress of Human Genetics in Montreal from the 11 to 15th of October. Sequenom had a boot at that Conference, I ask them and they reply that will be released early next year...
Carlos

Avatar of:

Posts: 0

October 26, 2011

A common editing mistake is to call trisomy 21 "Down's syndrome" when it is properly written "Down syndrome"---no possessive apostrophe S---

Avatar of:

Posts: 0

October 26, 2011

Hi Tyler,

Thanks for your comment. You are right that the accepted American spelling is Down syndrome. I have corrected this post to reflect that spelling.

Thanks for reading!
~Jef Akst, editor, The Scientist

Avatar of:

Posts: 0

October 26, 2011

Why they didn't announced at the International Congress of Human Genetics in Montreal from the 11 to 15th of October. Sequenom had a boot at that Conference, I ask them and they reply that will be released early next year...
Carlos

Avatar of:

Posts: 0

October 26, 2011

A common editing mistake is to call trisomy 21 "Down's syndrome" when it is properly written "Down syndrome"---no possessive apostrophe S---

Avatar of:

Posts: 0

October 26, 2011

Hi Tyler,

Thanks for your comment. You are right that the accepted American spelling is Down syndrome. I have corrected this post to reflect that spelling.

Thanks for reading!
~Jef Akst, editor, The Scientist

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies